Detection windows · stimulant

Cocaine detection windows

Cocaine is a short-acting stimulant. Workplace and clinical assays detect its primary metabolite, benzoylecgonine, which is highly specific and rarely subject to legitimate cross-reactivity.

Last updated:

How long is Cocaine detectable?

Detection windows for Cocaine vary by specimen, use pattern, and individual factors. As approximate ranges: urine commonly covers a few days (longer in chronic users), oral fluid covers hours to about 48 hours, blood covers hours, and hair offers up to ~90 days after a ~7–10 day incorporation delay. Full matrix below — and see the interactive Explorer for cross-substance comparisons.

Approximate detection windows for Cocaine
Specimen Window Pattern Caveat
Urine 1–3 days occasional Benzoylecgonine is the primary urinary marker.
3–7 days chronic Heavy use may extend benzoylecgonine excretion.
Saliva 1–48 hours typical Cocaine itself appears in oral fluid; detection is short.
Blood 1–12 hours typical Short plasma half-life; benzoylecgonine slightly longer.
Hair 7–90 days typical ~7–10 day incorporation delay; reflects historical not recent use.

Ranges are approximate and vary by individual physiology, hydration, dose, frequency of use, and lab cutoff. They are not predictive of whether someone will "pass" a test.

About Cocaine

Cocaine is a tropane alkaloid stimulant derived from the coca plant. Most testing programs target benzoylecgonine (BE), an inactive but highly specific metabolite produced by hydrolysis in plasma and liver.

Key analytes / metabolites detected

  • Benzoylecgonine (BE)
  • Ecgonine methyl ester
  • Norcocaine

Common cross-reactants (immunoassay-stage)

The following can affect screening immunoassay results and are typically resolved by mass-spectrometry confirmation and MRO review:

  • Coca tea (genuine ingestion, not cross-reactivity)

Appears in panels

Confirmation method

GC-MS or LC-MS/MS is the standard confirmation method for Cocaine.

Sources & references

drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.

  1. Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine) — SAMHSA
  2. 49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs — U.S. Department of Transportation